208. Corrected transposition of great arteries Disease details / Clinical trials / Drug dev / DR info /
Clinical trials : 2 / Drugs : 2 - (DrugBank : 0) / Drug target gene : 0 - Drug target pathway : 0
Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
Diovan
Novartis Pharma B.V.
2006 Phase 3 EUCTR2006-002262-19-NL Netherlands
SGLT2 inhibitors
Leiden University Medical Center
2023 - NCT06932081 Germany;Netherlands;North Macedonia;United Kingdom;United States
Novartis Pharma B.V.
2006 Phase 3 EUCTR2006-002262-19-NL Netherlands
SGLT2 inhibitors
Leiden University Medical Center
2023 - NCT06932081 Germany;Netherlands;North Macedonia;United Kingdom;United States
